GMP Manufacturing
GMP mRNA and LNP Manufacturing
Waisman offers a comprehensive range of platform mRNA and lipid nanoparticle manufacturing solutions, including custom template preparation, several platforms for in vitro transcription, variable scales based on stage of development, and custom lipid nanoparticle formulation to support non-clinical and clinical applications. Waisman has delivered mRNA-LNP products into several pre-IND programs and has the quality systems and production infrastructure to support through Phase 2 human clinical trials.
GMP mRNA Manufacturing Platform
Comprehensive Services
- CGMP plasmid template preparation
- mRNA process development, manufacturing, QC testing, and regulatory support
- Lipid Nanoparticle (LNP) formulation studies, fabrication, and QC testing
Robust Platform Manufacturing Process
- High yield mRNA in vitro transcription with custom reagent options including 5' capping
- High encapsulation rate with platform microfluidics equipment
- Milligram to gram capacity
- Integrated RNA + LNP and aseptic fill manufacturing processes
Phase-Appropriate Analytics
- Quality Control testing including capping and polyA tail
- In-house development of custom potency assays
Demonstrated Delivery
- Non-GMP mRNA-LNP delivered for preclinical research
- GMP mRNA-LNP delivered for first-in-human clinical trials
mRNA QC Testing
| Attribute | Method |
| mRNA Identity | Sequencing |
| Purity mRNA integrity | IP-RP-HPLC |
| mRNA concentration | UV-Vis |
| 5' capping efficiency | Custom MS |
| Poly A tail length | PAGE |
| pH | USP <791> |
| Safety | Endotoxin Bioburden Sterility Subvisible particulates |
| Potency | Custom |
Lipid Nanoparticle Formulation
Comprehensive Services
- Cytiva Ignite in-line mixing platform
- 10-100 ml batch sizes; potential to scale to 1000 ml
- Lipid options from a variety of commercial vendor sources
- Downstream tangential flow filtration (TFF) for custom dosing and final formulation
- Automated fill/finish with a validated platform aseptic process
Phase-Appropriate Analytics
- Platform methods for biophysical characteristics
- In-house development of custom potency assays
Demonstrated Delivery
- Non-GMP mRNA-LNP delivered for preclinical research
- Engineering batches delivered for non-human primate studies
RNA-LNP QC Testing
Add table of QC available here
| Attribute | Method |
| Lipid Identity | HPLC-CAD (contract vendor) |
Purity (including adduct formation) mRNA:gRNA ratios | IP-RP-HPLC |
| RNA Content | Ribogreen |
| Particle size, polydispersity, zeta potential | DLS |
| Osmolality | USP <785> |
| pH | USP <791> |
| Safety | Endotoxin Bioburden Sterility Subvisible particulates |
| Potency | Custom |
Scope of Services
